This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Duane Reade Lowers Third-Quarter Outlook

Duane Reade (DRD - Get Report) lowered its third-quarter earnings estimate, saying a drop in drug sales and the weakened economy were hurting its bottom line.

The New York company now expects to earn 8 cents to 9 cents a share, below its original expectation of 15 cents to 20 cents a share. Expected results have been adjusted for the impact of the Aug. 14 power outage .

Analysts foresee earnings of 18 cents a share, on average. The company earned 33 cents a share in the year-ago quarter.

"We continue to experience a sluggish economy and the related impact of persistent unemployment in the metro New York area," said CEO Anthony J. Cuti. "We believe that a significant portion of our challenges are attributable to our region's weak economy and are hopeful that the market will experience improved economic indicators as we enter the new fiscal year."

Sales in the quarter ended Sept. 30 were $338.6 million, which is $11.4 million below the company's prediction issued at the release of its second-quarter financial results. The company said the blackout cut sales by $3.3 million.

Same-store sales rose 3%, pharmacy same-store sales increased 8.6%, but front-end same-store sales fell 1.1%. Duane Reade said the power outage cut its same-store sales increase by about 1%.

The slowing growth rate of the prescription sector hurt business as well. Major contributors were the shift of Claritin and Prilosec from pharmacy to over-the-counter medications, an increased proportion of generic prescriptions filled, declines in hormone replacement prescriptions, and persistent unemployment, which has increased the number of uninsured in the population, Duane Reade said.

Looking to full-year 2003, the company sees earnings of 55 cents to 61 cents a share. Analysts expect 79 cents a share, however. The company earned $1.11 a share in 2002.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
DRD $1.71 -0.58%
AAPL $125.23 1.60%
FB $83.09 -0.25%
GOOG $548.74 0.07%
TSLA $184.12 -0.48%

Markets

DOW 17,960.43 +247.77 1.40%
S&P 500 2,081.59 +20.57 1.00%
NASDAQ 4,930.1680 +38.9490 0.80%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs